Micro-flow imaging multi-instrument evaluation for sub-visible particle detection
European Journal of Pharmaceutics and Biopharmaceutics · 2023-04 · 185 · 55-70
DOI: 10.1016/j.ejpb.2023.01.017 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Pharmaceutics and Biopharmaceutics, 2023-04. Verfasst von Ibrahim Fawaz und 4 weiteren Autor:innen. Beteiligte Einrichtung: Boehringer Ingelheim Pharma GmbH & Co. KG, Innovation Unit, Pharmaceutical Development Biologicals, 88397 Biberach an der Riss, Germany. Hauptthemen laut MEDLINE: Antibodies, Monoclonal, Biological Products. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 68 Literaturangaben.
Abstract (Originalsprache)
Sub-visible particles (SVPs) in pharmaceutical products are a critical quality attribute, and therefore should be monitored during development. Although light obscuration (LO) and microscopic particle count tests are the primary pharmacopeial methods used to quantify SVPs, flow imaging methods like Micro-Flow Imaging (MFI™) appear to overcome shortcomings of LO such as limited sensitivity concerning smaller translucent SVPs in the size range < 10 µm. Nowadays, MFI™ is routinely utilized during development of biologicals. Oftentimes multiple devices are distributed across several laboratories and departments. This poses challenges in data interpretation and consistency as well as in the use of multiple devices for one purpose. In this study, we systematically evaluated seven MFI™ instruments concerning their counting and size precision and accuracy, using an inter-comparable approach to mimic daily working routine. Therefore, we investigated three different types of particles (i) NIST certified counting standards, (ii) protein-coated particles, and (iii) stress-induced particles from a monoclonal antibody. We compared the results to alternative particle detection methods: LO and Backgrounded Membrane Imaging (BMI). Our results showed that the precision and accuracy of particle count and size, as well as the comparability of instruments, depended on the particle source and its material properties. The various MFI™ instruments investigated showed high precision (
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Boehringer Ingelheim Pharma GmbH & Co. KG, Innovation Unit, Pharmaceutical Development Biologicals, 88397 Biberach an der Riss, Germany.
- Boehringer Ingelheim Pharma GmbH & Co. KG, Analytical Development Biologicals, CMC Statistics, 88397 Biberach an der Riss, Germany.
- Boehringer Ingelheim Pharma GmbH & Co. KG, Innovation Unit, Pharmaceutical Development Biologicals, 88397 Biberach an der Riss, Germany. Electronic address: michaela.blech@boehringer-ingelheim.com.
Zitieren
APA
Fawaz, I., Schaz, S., Boehrer, A., Garidel, P., & Blech, M. (2023). Micro-flow imaging multi-instrument evaluation for sub-visible particle detection. European Journal of Pharmaceutics and Biopharmaceutics, 185, 55-70. https://doi.org/10.1016/j.ejpb.2023.01.017
Vancouver
Fawaz I, Schaz S, Boehrer A, Garidel P, Blech M. Micro-flow imaging multi-instrument evaluation for sub-visible particle detection. European Journal of Pharmaceutics and Biopharmaceutics. 2023;185:55-70. doi:10.1016/j.ejpb.2023.01.017
BibTeX
@article{Fawaz2023,
author = {Fawaz, Ibrahim and Schaz, Simone and Boehrer, Armin and Garidel, Patrick and Blech, Michaela},
title = {Micro-flow imaging multi-instrument evaluation for sub-visible particle detection},
journal = {European Journal of Pharmaceutics and Biopharmaceutics},
year = {2023},
volume = {185},
pages = {55--70},
doi = {10.1016/j.ejpb.2023.01.017}
}
EUVIMED